NCT04848402View on ClinicalTrials.gov

A Device Study in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

July 22, 2022

Study Completion Date

July 22, 2022

Conditions
Healthy
Interventions
DEVICE

On-Body Delivery System (OBDS)/Multiple Bolus Injector

Used to administer placebo SC.

DEVICE

Single Auto Injector

Used to administer placebo SC.

DRUG

Placebo

Administered SC.

Trial Locations (1)

LS2 9LH

LABCORP, Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04848402 - A Device Study in Healthy Participants | Biotech Hunter | Biotech Hunter